Scid Mice

The mutations interfere with the development of lymphocytes, the cells that support adaptive immune responses. As a result, functional T and B cells are greatly reduced or absent, so responses observed after introducing human cells, tissues, infections, or treatments occur without the full adaptive immune background found in immunocompetent mice. This makes the model useful for isolating human or disease-specific effects.

Prkdc is commonly affected in SCID mouse strains, and disruption of this gene is associated with severe loss of functional T and B cells. The resulting immune defect determines how effectively the animals can support transplanted human material and shapes the biological questions they can address. Researchers therefore consider the underlying mutation when selecting a model for a study.

Not all SCID mice have identical immune defects. Some strains also show impaired natural killer cell activity, adding another layer of immune suppression beyond the loss of effective T- and B-cell responses. This variation can influence how transplanted cells or tissues behave and should be considered when comparing results across strains or interpreting responses to disease and therapy.

SCID mice accept transplanted human cells and tissues more readily than immunocompetent animals because their adaptive immune defenses are severely compromised. This creates an experimental setting in which human biological material can be examined with less interference from mouse immune rejection. The approach supports studies of transplantation, human immune function, cancer, and responses to therapeutic interventions.

Humanized SCID models extend the system by incorporating human cells into an immunodeficient mouse context. They can therefore support investigations of interactions between human cells and disease processes that are difficult to examine using nonhuman immune components alone. This is especially relevant when researchers need to study human immune function alongside infection, cancer, transplantation, or therapeutic responses.

Their applications span several research areas identified in the source material: human immune function, infectious disease, cancer, transplantation, and therapeutic responses. The same underlying feature, reduced adaptive immunity, allows investigators to examine transplanted human material or disease-related processes in a living animal model. Humanized versions broaden these studies by adding more direct human cellular context.